Oct 2026· Drugs - Real World Outcomes· 0 citations· 18 references
Medicine
TL;DR
It is suggested that pharmacist-led interventions in chronic care settings may contribute to reducing medication burden and modifying prescribing patterns beyond simple medication count reduction.
Abstract
Background
Polypharmacy is a major challenge in geriatric pharmacotherapy and is associated with increased risks of adverse drug events, functional decline, and increased healthcare costs. Although pharmacist-led medication reviews improve prescription appropriateness, evidence regarding the sustained implementation of such interventions in chronic care hospitals remains limited.
Objective
This study aimed to evaluate the impact of a stepwise pharmacist-led polypharmacy management program on prescription patterns and medication costs among older inpatients in a chronic care hospital.
Methods
We conducted a single-center, retrospective observational study at a chronic care hospital in Japan, and included all inpatients hospitalized between January 2023 and December 2025. A multidisciplinary polypharmacy management program was introduced in 2024, followed by pharmacist-led comprehensive medication evaluation and management in 2025. The study period was categorized into three phases: preintervention (2023), implementation (2024), and comprehensive management (2025). The primary outcome was the monthly average number of regularly prescribed oral medications. The secondary outcomes included the prevalence of polypharmacy, defined as the concurrent use of ≥ 6 regularly prescribed medications, and hyperpolypharmacy, defined as ≥ 10 medications. The threshold of ≥ 6 medications was adopted because it is used as the criterion for polypharmacy management in the Japanese national healthcare reimbursement system. The threshold of ≥ 10 medications corresponds to our hospital's institutional criterion for identifying patients eligible for pharmacist-led comprehensive medication review.
Results
Approximately 320 inpatients were included monthly during the study period. The average number of prescribed medications decreased from 6.44 ± 3.37 in 2023 to 6.23 ± 3.52 in 2024 and 6.05 ± 3.47 in 2025. Regarding the rate of polypharmacy, the proportion of patients taking ≥ 6 or ≥ 10 medications decreased from 54.3% to 46.5% and from 18.4% to 15.5%, respectively. In contrast, the total annual medication costs showed no significant changes across the 3 years. Analysis according to therapeutic class demonstrated decreased costs for hypnotics/anxiolytics and nonsteroidal antiinflammatory drugs/paracetamol, whereas antithrombotic drug costs increased. The prescription volume measured by defined daily dose per 100 patients per day (DPD) remained generally stable, although intergroup differences were observed in 2025.
Conclusions
Pharmacist-led polypharmacy management was associated with changes in prescribing patterns and reductions in medication burden in this chronic care hospital. However, the reductions in the number of medications did not translate into short-term reductions in medication costs. These findings suggest that pharmacist-led interventions in chronic care settings may contribute to reducing medication burden and modifying prescribing patterns beyond simple medication count reduction. These findings also highlight the importance of using multiple indicators when evaluating deprescribing strategies.
Background: Polypharmacy has become an important challenge in geriatric care owing to the high prevalence of multimorbidity and age-related physiological changes that increase susceptibility to medication-related harm. Hospitalized older adults are particularly vulnerable to adverse drug reactions, drug–drug interactio...
Arpit Verma, S. Prajapati, Brijesh Kumar Gupta et al.· International Journal of Dru...· 0 citations
BACKGROUND
Pediatric and geriatric patients are at risk of adverse drug effects as a consequence of age factors on pharmacokinetics, multimorbidity, and multicomplicated therapy regimens. The purpose of this study was to assess the quality of prescriptions as far as adherence and pharmacoeconomic burden are concerned i...
Vignesh Sivakumar, J. N. Varma, P. Srinivas et al.· Indian Journal of Pharmacolo...· 0 citations
Overall, pharmacist-led medication review appears to be a promising strategy to support safer and more appropriate medication use among older adults with polypharmacy, although further well-designed studies are needed to clarify long-term clinical, humanistic, and economic outcomes.
Favian Rafif Firdaus, Alsita Salsabila Yulnanda, H. Pramestutie· Istanbul Journal of Pharmacy· 0 citations
Background: Elderly inpatients are disproportionately burdened by polypharmacy and potentially inappropriate medication (PIM) use, driven by age-related pharmacokinetic change, multimorbidity, and fragmented prescribing. Systematic Beers criteria-based prescription review is rarely practised in Indian tertiary care set...
Sarfaraz M., R. Biradar, Khuteja Parveen· International Journal of Com...· 0 citations
Elderly inpatients with polypharmacy and cardiovascular comorbidities represent the highest risk group for preventable DRPs, and proactive clinical pharmacist integration through daily ward rounds and medication reconciliation achieves a high rate of problem resolution, enhancing inpatient drug safety.
Anamika S. Patne, Shivakumar S. Ladde, Prajakta N. Sakhare et al.· PAIN, JOINTS, SPINE· 0 citations
Objective: Clinical pharmacists improve medication management and safety in intensive care units, yet their role in neonatal and pediatric intensive care remains highly variable across institutions. Evidence supporting standardized clinical pharmacy practice models in these settings is limited. This study evaluated the...
K. Parbouni, K. Henry, M. Heavner et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.